HealthCare Reports

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic Guidance for Industry, Investigators, and Institutional Review Boards, March 2020 Updated on March 27, 2020 - pdf (1.1 MB)

CRS: Freedom of Information Act (FOIA) Processing Changes Due to COVID-19: In Brief, March 27, 2020 - pdf (1.1 MB)

FDA: Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, March 2020 - pdf (173 kB)

Orange Cyberdefense: The threat of cyberattacks on healthcare establishments during the COVID-19 pandemic, March 2020 - pdf (1.6 MB)

FDA: Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic, March 2020 - pdf (178 kB)

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic, March 2020 - pdf (93 kB)

Pagina's